ArticleJournal of chemical information and modeling2026
ArtiDock: Accurate Machine Learning Approach to Protein-Ligand Docking Optimized for High-Throughput Virtual Screening.
Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Beyond the flat screen: evaluating virtual reality as a complementary tool for molecular docking in drug discovery.Journal of computer-aided molecular design · 2026Review
- Teaching diffusion models physics: reinforcement learning for physically valid diffusion-based docking.Chemical science · 2026Article
- Lab to codes: multimodel advanced AI-driven pipelines to drive antimicrobial peptide design for the post-antibiotic era.Frontiers in cellular and infection microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Classical protein-ligand docking has been a cornerstone technique in computational drug discovery for decades but has reached an accuracy and performance plateau. Recently introduced Machine Learning (ML)-based docking methods offer a promising paradigm shift, but their practical adoption is hampered by accuracy-to-speed trade-offs, inadequate benchmarking standards, and questionable chemical validity of predicted poses. In this study, we introduce ArtiDock─an ML-based docking technique optimized for high-throughput virtual screening applications. To evaluate ArtiDock, we developed a dedicated performance and accuracy benchmark for pocket-specific rigid protein-ligand docking, which mimics realistic industrial drug discovery scenarios and is based on the novel PLINDER data set. We demonstrate that ArtiDock is 29-38% more accurate in comparison to leading open-source and commercial classical docking techniques such as AutoDock, Vina, and Glide, while providing a low computational cost. ArtiDock notably excels in challenging docking scenarios involving unbound protein structures and binding sites containing ions and structured water molecules. Additionally, we demonstrated competitive accuracy of our approach at considerably higher throughput compared to a wide range of AI docking and AI cofolding methods using the PoseX benchmark. Our results show that ArtiDock could be considered as a method of choice in high-throughput virtual screening scenarios.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.